Shanghai Labway Clinical Laboratory Co., Ltd.

SZSE:301060.SZ

12.86 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 450.408436.441404.492431.966425.322412.5881,090.4791,048.1691,232.967827.69503.748503.294414.894356.397374.467363.201341.232159.29325.491241.293241.293245.551245.551156.773156.773185.369185.369118.866118.866
Cost of Revenue 355.306340.837367.238336.353329.888292.606660.583651.468666.102430.734325.026296.031261.726218.437266.611-333.746333.746148.70164.93164.93174.589174.58992.76992.769119.214119.21478.26478.264
Gross Profit 95.10295.60437.25495.61395.434119.982429.896396.702566.866396.956178.722207.262153.168137.96107.857696.9477.48610.59325.49176.36376.36370.96170.96164.00364.00366.15566.15540.60240.602
Gross Profit Ratio 0.2110.2190.0920.2210.2240.2910.3940.3780.460.480.3550.4120.3690.3870.2881.9190.0220.06610.3160.3160.2890.2890.4080.4080.3570.3570.3420.342
Reseach & Development Expenses 17.3919.98616.16213.0688.8810.75461.07816.61519.21512.49316.4487.7319.2036.0595.9516.0830000000000000
General & Administrative Expenses -19.47541.857-76.174113.505-20.65342.503-155.19208.594-25.39462.505-62.933107.13644.85928.54133.04433.16300033.06733.06734.1534.1522.37922.37917.88617.88613.36313.363
Selling & Marketing Expenses 20.54617.25128.8723.4312521.38647.5840.05354.92641.56248.25723.94329.18124.10228.28120.58400014.86914.86921.58621.5869.8689.86810.02210.0225.6165.616
SG&A 67.93959.108-47.304136.9364.34763.888-107.61248.64729.532104.067-14.677131.0881.05658.04376.68948.90700047.93647.93655.73655.73632.24732.24727.90827.90818.97918.979
Other Expenses -3.078-0.402-12.261-0.158-2.085-15.365262.336-147.467147.975-2.288126.137-56.139-343.944-278.729-344.351-629.47962.805-148.7-301.9370000000000
Operating Expenses 88.40868.32103.13282.70177.28659.277215.804117.794196.722114.272127.90882.672-343.944-278.729-344.351-629.47962.805-148.7-301.93748.25248.25255.11355.11336.19436.19429.97229.97221.79621.796
Operating Income 6.6942.721-141.49611.802-28.67322.54356.544258.646354.359279.72648.128122.20170.9577.66830.11767.46970.29110.5923.55431.96231.96214.23114.23131.02431.02437.33937.33920.94820.948
Operating Income Ratio 0.0150.006-0.350.027-0.0670.0550.0520.2470.2870.3380.0960.2430.1710.2180.080.1860.2060.0660.0720.1320.1320.0580.0580.1980.1980.2010.2010.1760.176
Total Other Income Expenses Net 2.668-24.966-162.856-0.158-2.085-2.915-32.184-6.899-2.678-3.071-1.1850.818271.967-279.033704.118-713.542141.494-156.89715.048-2.565-2.5651.6171.617-3.214-3.214-1.155-1.155-2.141-2.141
Income Before Tax 9.3622.319-153.75711.643-30.75719.62824.361251.747351.681276.65546.943123.01970.70577.36427.52463.81168.5732.424.2729.39729.39715.84915.84927.8127.8136.18336.18318.80718.807
Income Before Tax Ratio 0.0210.005-0.380.027-0.0720.0480.0220.240.2850.3340.0930.2440.170.2170.0740.1760.2010.0150.0750.1220.1220.0650.0650.1770.1770.1950.1950.1580.158
Income Tax Expense -1.4792.584-1.4153.2142.634.03718.22945.53356.12945.49710.42219.615298.056-254.685716.699-692.056157.651-139.025725.0326.6936.6937.1437.1436.4116.4119.3189.3184.5174.517
Net Income 14.5261.072-140.7110.943-23.23615.5916.132173.77253.309177.23936.52179.18244.86153.3217.53645.98354.133-7.27513.5721.79821.7988.0398.03921.34321.34326.86626.86614.2914.29
Net Income Ratio 0.0320.002-0.3480.002-0.0550.0380.0060.1660.2050.2140.0720.1570.1080.150.0470.1270.159-0.0460.0420.090.090.0330.0330.1360.1360.1450.1450.120.12
EPS 0.0360.003-0.350.002-0.0580.0390.0150.430.630.440.0910.20.110.150.0440.110.14-0.0180.0340.170.170.0830.0830.230.230.2950.110.0440.04
EPS Diluted 0.0360.003-0.350.002-0.0580.0390.0150.430.630.440.0910.20.110.150.0440.110.14-0.0180.0340.170.170.0830.0830.230.230.2950.110.0440.04
EBITDA 30.66330.102-77.06613.98115.95758.552181.295271.47368.585281.92651.254127.664-206.722356.397-676.594777.353-72.92159.29-696.48138.20138.20119.05819.05835.8835.8840.67840.67823.63823.638
EBITDA Ratio 0.0680.069-0.1910.0320.0380.1420.1660.2590.2990.3410.1020.254-0.4981-1.8072.14-0.2141-2.140.1580.1580.0780.0780.2290.2290.2190.2190.1990.199